9 months ago
INSM
AnalystsOlivia BrayerOlivia Brayer's Stock Forecasts
AnalystsOlivia Brayer
Sectors:
Industries:
Analyst Ranking
Top 29%
#1579 out of 5511 analysts
Average Return
+2.96%
Win Rate
48%30 out of 63
Risk vs Reward
Poor
Good
Olivia Brayer's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Aurinia Pharmaceuticals IncAUPH | +79.66% | $7.13 | $12.81 | 2024-09-16 - 2025-09-15 | Strong Buy |
Aurinia Pharmaceuticals IncAUPH | +79.04% | $6.87 | $12.30 | 2024-09-09 - 2025-09-08 | Strong Buy |
United Therapeutics CorpUTHR | +67.33% | $325.48 | $544.62 | 2025-06-02 - 2026-06-01 | Strong Buy |
Vanda Pharmaceuticals IncVNDA | +64.03% | $3.92 | $6.43 | 2025-05-14 - 2026-05-13 | Strong Buy |
Inhibikase Therapeutics IncIKT | +51.48% | $1.53 | $2.31 | 2025-12-11 - 2026-09-15 | Strong Buy |
Olivia Brayer Analyst Color
Get additional color on Olivia Brayer's coverage of popular stocks
Olivia Brayer's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Connect Biopharma Holdings LtdCNTB | 1 | Strong Buy | $4.00 | +241.88% | Initiates Coverage On | 4 months ago |
Gossamer Bio IncGOSS | 2 | Hold | N/A | N/A | Downgrades | 6 months ago |
Cytomx Therapeutics IncCTMX | 2 | Strong Buy | $10.00 | +271.75% | Maintains | 7 months ago |
Insmed IncINSM | 1 | Strong Buy | $230.00 | +91.79% | Maintains | 9 months ago |
Inhibikase Therapeutics IncIKT | 1 | Strong Buy | $4.00 | +73.16% | Initiates Coverage On | 9 months ago |
Vanda Pharmaceuticals IncVNDA | 2 | Strong Buy | $11.00 | +120.44% | Maintains | a year ago |
United Therapeutics CorpUTHR | 2 | Strong Buy | $525.00 | N/A | Maintains | a year ago |
Verona Pharma PLCVRNA | 1 | Strong Buy | $100.00 | N/A | Maintains | a year ago |
Biomarin Pharmaceutical IncBMRN | 14 | Strong Buy | $90.00 | N/A | Reiterates | 2 years ago |
Vertex Pharmaceuticals IncVRTX | 22 | Strong Buy | $480.00 | N/A | Reiterates | 2 years ago |
Bristol Myers Squibb CoBMY | 9 | Hold | $55.00 | N/A | Maintains | 2 years ago |
Gilead Sciences IncGILD | 10 | Hold | $80.00 | N/A | Reiterates | 2 years ago |
Omeros CorpOMER | 1 | Hold | N/A | N/A | Reiterates | 2 years ago |
Regeneron Pharmaceuticals IncREGN | 8 | Hold | $1,015.00 | N/A | Reiterates | 2 years ago |
Amgen IncAMGN | 2 | Strong Buy | $405.00 | N/A | Reiterates | 2 years ago |
Alnylam Pharmaceuticals IncALNY | 19 | Hold | $220.00 | N/A | Reiterates | 2 years ago |
Aurinia Pharmaceuticals IncAUPH | 5 | Strong Buy | $10.00 | N/A | Reiterates | 2 years ago |
Mannkind CorpMNKD | 3 | Strong Buy | $6.50 | N/A | Reiterates | 2 years ago |
Crispr Therapeutics AgCRSP | 1 | Strong Buy | $72.00 | N/A | Initiates Coverage On | 3 years ago |
Lenz Therapeutics IncLENZ | 2 | Hold | $3.00 | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.